⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVO News
Novo-Nordisk A/S
Hepta Reveals Blood-Based Epigenetic Signatures of GLP-1 Response, Enabling Precision Medicine in Obesity and MASH
businesswire.com
NVO
Ozempic Market to Surpass USD 61.92 Billion by 2035 as GLP-1 Therapies Transform Diabetes and Obesity Care | SNS Insider
globenewswire.com
NVO
Novo Nordisk A/S - share repurchase programme
globenewswire.com
NVO
People & Planet United Summit Brings Together Cross-Sector Voices to Advance Health, AI Innovation, and Global Responsibility
prnewswire.com
MSFT
NVO
Parker Waichman LLP Files Lawsuit on behalf of South Carolina Resident Alleging Development of Irreversible Eye Condition, NAION, after taking Ozempic
prnewswire.com
NVO
Refills GLP-1 Weight Loss Claims Evaluated: The Most Affordable Personalized Semaglutide & Tirzepatide GLP1 Program with Online Doctor Support
globenewswire.com
LLY
NVO
Novo Nordisk's Ozempic® pill, the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes, soon to be available in the US
prnewswire.com
NVO
What the U.S. Pharmaceutical Industry Could Learn from How Africa Solves Patient Access
accessnewswire.com
PFE
SNY
NVO
WEBINAR INVITATION: Novo Resources Corp. Executive Co-Chairman to discuss the March Quarter Activities and Outlook
globenewswire.com
NVO
SQM
Novolog or Novomix or NovoRapid (Novo Nordisk) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
NVO